NUS250117P12500
- 0.00
- 0.000.00%
Nu Skin Enterprises Newsroom
Nu Skin Enterprises (NYSE:NUS) Is Finding It Tricky To Allocate Its Capital
NUS Q4 Preliminary Revenues Reach Top End of Outlook, Stock Gains 9.8%
Nu Skin Enterprises Expects Q4 Revenue to Reach High End of Guidance -- Shares Rise
Nu Skin (NUS) Shares Skyrocket, What You Need To Know
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
Press Release: Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance
Nu Skin Says Q4 Preliminary Revenue at High End of Guidance
Express News | Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance
Institutional Owners May Take Dramatic Actions as Nu Skin Enterprises, Inc.'s (NYSE:NUS) Recent 17% Drop Adds to One-year Losses
D.A. Davidson Maintains Nu Skin Enterprises(NUS.US) With Hold Rating, Maintains Target Price $7
Jefferies Maintains Nu Skin Enterprises(NUS.US) With Hold Rating, Cuts Target Price to $7
Nu Skin Enterprises Up Over 23%, on Pace for Largest Percent Increase Since July 2020 -- Data Talk
Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday
Nu Skin (NUS) Up 17% at Pre-Market Trade After Raising $250M Fresh Funds
Sector Update: Consumer Stocks Steady Premarket Friday
Sector Update: Consumer
Why Is Nu Skin Enterprises Stock Jumping Today?
Correction to Nu Skin Shares Rise Premarket Article
Nu Skin Shares Rise Premarket on Sale of Mavely Platform
Nu Skin to Use Proceeds From Sale to Pay Down Debt, Fund Innovation >NUS